Skip to main content
. 2022 Mar 11;13(4):619–634. doi: 10.1007/s13300-022-01222-2

Fig. 1.

Fig. 1

Triggers for considering simplification. CHD coronary heart disease, CKD chronic kidney disease, GLP-1 RA glucagon-like peptide 1 receptor agonist, PAD peripheral arterial disease, PVD peripheral vascular disease, QoL quality of life, SGLT-2i sodium-glucose co-transporter 2 inhibitor